UK markets close in 5 hours 10 minutes

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.6100-0.1000 (-3.69%)
At close: 04:00PM EDT
2.6400 +0.10 (+3.94%)
Pre-market: 05:40AM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-378
-1,782
-1,348
435
-2,954
-
Depreciation & amortisation
-
0
1
1
1
-
Stock-based compensation
-
3
14
37
51
-
Change in working capital
-
64
-19
-54
45
-
Accounts payable
-
19
-44
-23
22
-
Other working capital
-
-707
-901
-1,049
-851
-
Other non-cash items
-
-41
-36
-8
-33
-
Net cash provided by operating activities
-
-707
-901
-1,049
-850
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-1
-2
Purchases of investments
-
-
-
-
0
0
Sales/maturities of investments
-
-
-
0
0
2,020
Net cash used for investing activities
-
41
36
8
32
-
Cash flows from financing activities
Common stock issued
-
-
-
-
-
0
Net cash used provided by (used for) financing activities
-
0
0
385
0
-
Net change in cash
-
-666
-865
-656
-818
-
Cash at beginning of period
-
2,094
2,969
3,631
4,455
-
Cash at end of period
-
1,401
2,094
2,969
3,631
-
Free cash flow
Operating cash flow
-
-707
-901
-1,049
-850
-
Capital expenditure
-
-
-
-
-1
-2
Free cash flow
-
-707
-901
-1,049
-851
-